Oxford/AstraZeneca: AZD1222

Vaccine Type: Non Replicating Viral Vector

Developers: AstraZeneca, Iqvia Pty Ltd, Covance

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 3: 5 Trials

Approvals: 7 Approvals

  • Argentina
  • Dominican Republic
  • El Salvador
  • India
  • Mexico
  • Morocco
  • United Kingdom

This vaccine is also manufactured by the Serum Institute of India (Covishield)

Registered Trials